The International Society for Stem Cell Application (ISSCA), founded and operated by stem cell company N-BIOTEK since 2016, announced that it held the WORLD CONGRESS event in Istanbul, Turkiye, from September 23 to 25. The event, co-hosted by Regen Clinic, a Turkish partner of N-BIOTEK, and the Global Stemcell Group of the United States, participated as speakers in Turkiye, the United Kingdom, the United States, Spain, Indonesia, Dubai, India, Pakistan, Brazil, Mexico, and other countries to share various research and clinical practices in stem cells. During the conference, more than 200 participants from around the world confirmed that the need and interest in stem cell therapy and regenerative medical technology have increased during the COVID-19 pandemic.
Daeyong Kim , CEO of N-BIOTEK, who is the founder and current president of the conference, said in a keynote speech to mark the start of the event on September 23, "As the world experiences the importance of disease prevention and treatment, the international community is expected to increase the expectation and demand for regenerative medicine in the post-corona era.".
Accordingly, N-BIOTEK and CEO Daeyong Kim plan to continue to hold conferences, seminars, and hands-on training involving high-tech regenerative medical experts at home and abroad to play a leading role in the development of regenerative medical technology and treatment development.